Pfizer antibacterial gets FDA warning
Federal authorities told doctors Wednesday that a new analysis of studies involving Pfizer Inc.'s intravenous antibacterial Tygacil showed the treatment resulted in more deaths than other drugs targeting serious infections.
"The increased risk was seen most clearly in patients treated for hospital-acquired pneumonia, especially ventilator-associated pneumonia, but was also seen in patients with complicated skin and skin structure infections, complicated intra-abdominal infections and diabetic foot infections," the U.S. Food and Drug Administration warned.
The FDA said "alternatives to Tygacil should be considered in patients with severe infections."
- Lee Howard
Most Recent Poll
Read the transcript of the chat with New London Mayor Finizio
The Day hosted a web chat with New London Mayor Daryl J. Finizio to discuss the beginning of his new administration and news out of the city's police department.
Popular on theday.com
Most-Read Stories
Most-Viewed Multimedia
Most-Discussed Stories
-
New London to keep a closer eye on state of its wallet (31)
-
NLDC getting a new identity (25)
-
Finizio pledges closer association with city council (25)
-
New London needs to change course to integrate its fire department (24)
-
Ad agency still searching for Connecticut's identity (24)
-
New London hopes 'CAPT Academy' boosts scores 5 percent (21)
-
No indictments for Westerly police in Mystic man's death (18)
-
Food stamps feed unfortunate need (16)
Quick Links 
860-442-2200
The Day Publishing Company
New London, CT USA
Copyright © 1998
HIDE COMMENTS
HIDE COMMENTS